Breaking News Instant updates and real-time market news.

GS

Goldman Sachs

$160.28 /

+6.89 (+4.49%)

14:05
03/25/20
03/25
14:05
03/25/20
14:05

Goldman Sachs call volume above normal and directionally bullish

Bullish option flow detected in Goldman Sachs with 11,109 calls trading, 1.2x expected, and implied vol increasing almost 3 points to 75.49%. Apr-20 150 puts and Jun-20 230 calls are the most active options, with total volume in those strikes near 3,000 contracts. The Put/Call Ratio is 0.60. Earnings are expected on April 15th.

  • 15

    Apr

GS Goldman Sachs
$160.28 /

+6.89 (+4.49%)

03/16/20 Citi
Goldman Sachs price target lowered to $260 from $290 at Citi
02/28/20 Wells Fargo
Wells Fargo cuts large-cap bank estimates, but notes balance sheet strength
02/20/20 Wells Fargo
Wells Fargo downgrades Morgan Stanley after 'value destroying' E-Trade deal
02/05/20 Citi
Goldman Sachs price target raised to $290 from $255 at Citi

TODAY'S FREE FLY STORIES

Hot Stocks
Remark Holdings partners with Hanvon Technology » 09:04
06/01/20
06/01
09:04
06/01/20
09:04
MARK

Remark Holdings

$2.61 /

-0.35 (-11.82%)

Remark Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MARK Remark Holdings
$2.61 /

-0.35 (-11.82%)

MARK Remark Holdings
$2.61 /

-0.35 (-11.82%)

05/27/20 Roth Capital
Wynn video 'clearly shows' Remark AI technology in use, says Roth Capital
07/15/19 Roth Capital
Sharecare liquidity event would help capitalize Remark AI business, says Roth Capital
MARK Remark Holdings
$2.61 /

-0.35 (-11.82%)

MARK Remark Holdings
$2.61 /

-0.35 (-11.82%)

Recommendations
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley » 09:03
06/01/20
06/01
09:03
06/01/20
09:03
LLY

Eli Lilly

$153.14 /

+2.51 (+1.67%)

, PFE

Pfizer

$38.14 /

-0.03 (-0.08%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$153.14 /

+2.51 (+1.67%)

PFE Pfizer
$38.14 /

-0.03 (-0.08%)

LLY Eli Lilly
$153.14 /

+2.51 (+1.67%)

05/29/20 Raymond James
Blueprint approval for pralsetinib could come before PDUFA, says Raymond James
04/24/20 Cantor Fitzgerald
Eli Lilly price target raised to $185 from $156 at Cantor Fitzgerald
04/24/20 Mizuho
Eli Lilly price target raised to $155 from $148 at Mizuho
04/21/20
Fly Intel: Top five analyst downgrades
PFE Pfizer
$38.14 /

-0.03 (-0.08%)

08:06 Today Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
05/15/20 Goldman Sachs
After Pfizer data, Goldman says Sarepta remains 'leader' in DMD gene therapy
LLY Eli Lilly
$153.14 /

+2.51 (+1.67%)

PFE Pfizer
$38.14 /

-0.03 (-0.08%)

LLY Eli Lilly
$153.14 /

+2.51 (+1.67%)

PFE Pfizer
$38.14 /

-0.03 (-0.08%)

LLY Eli Lilly
$153.14 /

+2.51 (+1.67%)

PFE Pfizer
$38.14 /

-0.03 (-0.08%)

PFE Pfizer
$38.14 /

-0.03 (-0.08%)

Hot Stocks
Fatburger, Buffalo's Express debut in Texas » 09:03
06/01/20
06/01
09:03
06/01/20
09:03
FAT

Fat Brands

$3.18 /

-0.02 (-0.63%)

FAT Brands announces the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FAT Fat Brands
$3.18 /

-0.02 (-0.63%)

Initiation
JPMorgan starts CarMax with Overweight rating, $105 price target » 09:02
06/01/20
06/01
09:02
06/01/20
09:02
KMX

CarMax

$88.04 /

-0.725 (-0.82%)

JPMorgan analyst Rajat…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KMX CarMax
$88.04 /

-0.725 (-0.82%)

KMX CarMax
$88.04 /

-0.725 (-0.82%)

04:44 Today JPMorgan
CarMax initiated with an Overweight at JPMorgan
05/12/20
Fly Intel: Top five analyst upgrades
05/12/20 Wedbush
CarMax upgraded to Outperform at Wedbush on stronger bounce-back
05/12/20 Wedbush
CarMax upgraded to Outperform from Neutral at Wedbush
KMX CarMax
$88.04 /

-0.725 (-0.82%)

KMX CarMax
$88.04 /

-0.725 (-0.82%)

KMX CarMax
$88.04 /

-0.725 (-0.82%)

KMX CarMax
$88.04 /

-0.725 (-0.82%)

Hot Stocks
Cigna expands, extends COVID-19 relief efforts » 09:02
06/01/20
06/01
09:02
06/01/20
09:02
CI

Cigna

$197.08 /

-3.43 (-1.71%)

Effective immediately,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CI Cigna
$197.08 /

-3.43 (-1.71%)

CI Cigna
$197.08 /

-3.43 (-1.71%)

05/04/20 Bernstein
Cigna downgraded to Market Perform at Bernstein
05/04/20 Bernstein
Cigna downgraded to Market Perform from Outperform at Bernstein
05/04/20 Raymond James
Cigna price target raised to $240 from $210 at Raymond James
05/04/20 Deutsche Bank
Cigna price target lowered to $279 from $288 at Deutsche Bank
CI Cigna
$197.08 /

-3.43 (-1.71%)

CI Cigna
$197.08 /

-3.43 (-1.71%)

CI Cigna
$197.08 /

-3.43 (-1.71%)

CI Cigna
$197.08 /

-3.43 (-1.71%)

Hot Stocks
eXp World Holdings appoints Felicia Gentry to board of directors » 09:02
06/01/20
06/01
09:02
06/01/20
09:02
EXPI

eXp World Holdings

$10.69 /

+0.56 (+5.53%)

eXp World Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXPI eXp World Holdings
$10.69 /

+0.56 (+5.53%)

EXPI eXp World Holdings
$10.69 /

+0.56 (+5.53%)

04/20/20 Stephens
Stephens ups CoreLogic, downgrades two others in real estate services shake-up
EXPI eXp World Holdings
$10.69 /

+0.56 (+5.53%)

Recommendations
Zscaler price target raised to $105 from $63 at BMO Capital » 09:01
06/01/20
06/01
09:01
06/01/20
09:01
ZS

Zscaler

$98.09 /

+22.21 (+29.27%)

BMO Capital analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$98.09 /

+22.21 (+29.27%)

ZS Zscaler
$98.09 /

+22.21 (+29.27%)

05/29/20 Baird
Zscaler price target raised to $100 from $80 at Baird
05/29/20 Rosenblatt
Zscaler price target raised to $115 from $75 at Rosenblatt
05/29/20 DA Davidson
Zscaler price target raised to $105 from $65 at DA Davidson
05/29/20 Cowen
Zscaler price target raised to $100 from $80 at Cowen
ZS Zscaler
$98.09 /

+22.21 (+29.27%)

ZS Zscaler
$98.09 /

+22.21 (+29.27%)

ZS Zscaler
$98.09 /

+22.21 (+29.27%)

ZS Zscaler
$98.09 /

+22.21 (+29.27%)

Downgrade
XP Inc. downgraded to Neutral from Overweight at JPMorgan » 09:00
06/01/20
06/01
09:00
06/01/20
09:00
XP

XP Inc.

$30.30 /

-0.14 (-0.46%)

JPMorgan analyst Domingos…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XP XP Inc.
$30.30 /

-0.14 (-0.46%)

XP XP Inc.
$30.30 /

-0.14 (-0.46%)

04/27/20 BofA
XP Inc. downgraded to Underperform from Neutral at BofA
04/03/20 Citi
XP Inc. upgraded to Buy from Neutral at Citi
01/27/20 BTG Pactual
XP Inc. initiated with a Neutral at BTG Pactual
01/06/20 Morgan Stanley
Morgan Stanley starts XP Inc. at Overweight with $45 price target
XP XP Inc.
$30.30 /

-0.14 (-0.46%)

XP XP Inc.
$30.30 /

-0.14 (-0.46%)

XP XP Inc.
$30.30 /

-0.14 (-0.46%)

Hot Stocks
Iterum Therapeutics PLC trading resumes  09:00
06/01/20
06/01
09:00
06/01/20
09:00
ITRM

Iterum Therapeutics

$4.23 /

-0.14 (-3.20%)

 
ShowHide Related Items >><<
ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

01/21/20 Gabelli
Iterum Therapeutics downgraded to Sell from Buy at Gabelli
12/11/19 RBC Capital
Iterum Therapeutics price target lowered to $10 from $14 at RBC Capital
12/11/19 SVB Leerink
Iterum Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
06/21/19 H.C. Wainwright
Iterum Therapeutics initiated with a Buy at H.C. Wainwright
ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

Hot Stocks
Novus Therapeutics trading resumes  09:00
06/01/20
06/01
09:00
06/01/20
09:00
NVUS

Novus Therapeutics

$1.27 /

-0.03 (-2.31%)

 
ShowHide Related Items >><<
NVUS Novus Therapeutics
$1.27 /

-0.03 (-2.31%)

NVUS Novus Therapeutics
$1.27 /

-0.03 (-2.31%)

11/27/19
Fly Intel: Top analyst initiations
11/27/19 H.C. Wainwright
Novus Therapeutics initiated with a Buy at H.C. Wainwright
NVUS Novus Therapeutics
$1.27 /

-0.03 (-2.31%)

Upgrade
Gap upgraded to Neutral from Underweight on valuation at JPMorgan » 08:57
06/01/20
06/01
08:57
06/01/20
08:57
GPS

Gap

$8.92 /

-0.66 (-6.89%)

JPMorgan analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GPS Gap
$8.92 /

-0.66 (-6.89%)

GPS Gap
$8.92 /

-0.66 (-6.89%)

05:41 Today JPMorgan
Gap upgraded to Neutral from Underweight at JPMorgan
04/27/20 Barclays
Gap price target lowered to $5 from $10 at Barclays
04/24/20 RBC Capital
Gap price target lowered to $8 from $14 at RBC Capital
04/23/20
Fly Intel: Top five analyst upgrades
GPS Gap
$8.92 /

-0.66 (-6.89%)

GPS Gap
$8.92 /

-0.66 (-6.89%)

GPS Gap
$8.92 /

-0.66 (-6.89%)

GPS Gap
$8.92 /

-0.66 (-6.89%)

Recommendations
DXC Technology price target lowered to $16 from $42 at BMO Capital » 08:57
06/01/20
06/01
08:57
06/01/20
08:57
DXC

DXC Technology

$14.32 /

-2.245 (-13.56%)

BMO Capital analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DXC DXC Technology
$14.32 /

-2.245 (-13.56%)

DXC DXC Technology
$14.32 /

-2.245 (-13.56%)

05/29/20
Fly Intel: Top five analyst downgrades
05/29/20 JPMorgan
JPMorgan downgrades DXC to Neutral on dividend suspension
05/29/20 JPMorgan
DXC Technology downgraded to Neutral from Overweight at JPMorgan
03/12/20 MoffettNathanson
DXC Technology upgraded to Buy from Neutral at MoffettNathanson
DXC DXC Technology
$14.32 /

-2.245 (-13.56%)

DXC DXC Technology
$14.32 /

-2.245 (-13.56%)

DXC DXC Technology
$14.32 /

-2.245 (-13.56%)

DXC DXC Technology
$14.32 /

-2.245 (-13.56%)

Hot Stocks
Rekor Systems announces venture to launch » 08:55
06/01/20
06/01
08:55
06/01/20
08:55
REKR

Rekor Systems

$3.54 /

+0.02 (+0.57%)

Rekor Systems and Cygnet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REKR Rekor Systems
$3.54 /

+0.02 (+0.57%)

REKR Rekor Systems
$3.54 /

+0.02 (+0.57%)

04/14/20 B. Riley FBR
Rekor Systems initiated with Buy on 'significant' opportunity at B. Riley FBR
04/14/20 B. Riley FBR
Rekor Systems initiated with a Buy at B. Riley FBR
Options
Notable open interest changes for June 1st » 08:55
06/01/20
06/01
08:55
06/01/20
08:55
ECL

Ecolab

$212.85 /

+1.47 (+0.70%)

, UBER

Uber

$36.34 /

+2.175 (+6.37%)

, ZNGA

Zynga

$9.14 /

+1.075 (+13.33%)

, APY

Apergy

$9.06 /

+0.14 (+1.57%)

Friday's total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ECL Ecolab
$212.85 /

+1.47 (+0.70%)

UBER Uber
$36.34 /

+2.175 (+6.37%)

ZNGA Zynga
$9.14 /

+1.075 (+13.33%)

APY Apergy
$9.06 /

+0.14 (+1.57%)

ECL Ecolab
$212.85 /

+1.47 (+0.70%)

04/16/20 Spin-Off Research
Ecolab initiated with a Hold at Spin-Off Research
04/06/20 BMO Capital
Ecolab price target lowered to $171 from $216 at BMO Capital
03/20/20 Deutsche Bank
Ecolab price target lowered to $170 from $220 at Deutsche Bank
03/17/20 JPMorgan
JPMorgan downgrades Ecolab to Underweight, cuts target to $152
UBER Uber
$36.34 /

+2.175 (+6.37%)

05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/27/20 Northcoast
Ride hailing drivers believe April marked the bottom, says Northcoast
05/26/20 Wolfe Research
Uber upgraded to Outperform from Peer Perform at Wolfe Research
05/15/20 Wedbush
Uber's potential GrubHub deal an offensive and defensive move, says Wedbush
ZNGA Zynga
$9.14 /

+1.075 (+13.33%)

05/07/20 Baird
Zynga guidance appears conservative, says Baird
05/07/20 Piper Sandler
Zynga price target raised to $8.50 from $8 at Piper Sandler
04/22/20
Fly Intel: Top five analyst downgrades
04/22/20 BofA
Zynga downgraded to Underperform from Neutral at BofA
APY Apergy
$9.06 /

+0.14 (+1.57%)

06:16 Today Citi
Apergy upgraded to Buy from Neutral at Citi
03/19/20 Wolfe Research
Apergy downgraded to Peer Perform from Outperform at Wolfe Research
03/13/20 Wells Fargo
Drillers downgraded at Wells Fargo on recent sell off in commodity prices
03/09/20 BofA
Apergy downgraded to Neutral from Buy at BofA
ECL Ecolab
$212.85 /

+1.47 (+0.70%)

UBER Uber
$36.34 /

+2.175 (+6.37%)

ZNGA Zynga
$9.14 /

+1.075 (+13.33%)

APY Apergy
$9.06 /

+0.14 (+1.57%)

UBER Uber
$36.34 /

+2.175 (+6.37%)

ZNGA Zynga
$9.14 /

+1.075 (+13.33%)

ECL Ecolab
$212.85 /

+1.47 (+0.70%)

UBER Uber
$36.34 /

+2.175 (+6.37%)

ZNGA Zynga
$9.14 /

+1.075 (+13.33%)

APY Apergy
$9.06 /

+0.14 (+1.57%)

ECL Ecolab
$212.85 /

+1.47 (+0.70%)

UBER Uber
$36.34 /

+2.175 (+6.37%)

ZNGA Zynga
$9.14 /

+1.075 (+13.33%)

APY Apergy
$9.06 /

+0.14 (+1.57%)

General news
FX Action: USD-CAD » 08:55
06/01/20
06/01
08:55
06/01/20
08:55

FX Action: USD-CAD traded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
Merck CEO to CNBC: George Floyd 'could be me' » 08:54
06/01/20
06/01
08:54
06/01/20
08:54
MRK

Merck

$80.85 /

+1.83 (+2.32%)

Merck CEO Ken Frazier…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$80.85 /

+1.83 (+2.32%)

MRK Merck
$80.85 /

+1.83 (+2.32%)

05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
04/27/20 SVB Leerink
Clovis downgraded to Underperform at SVB Leerink as prostate opportunity fades
04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
MRK Merck
$80.85 /

+1.83 (+2.32%)

MRK Merck
$80.85 /

+1.83 (+2.32%)

MRK Merck
$80.85 /

+1.83 (+2.32%)

MRK Merck
$80.85 /

+1.83 (+2.32%)

Upgrade
Arvinas upgraded to Buy from Neutral at Citi » 08:54
06/01/20
06/01
08:54
06/01/20
08:54
ARVN

Arvinas

$33.26 /

-11.52 (-25.73%)

Citi analyst Yigal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARVN Arvinas
$33.26 /

-11.52 (-25.73%)

ARVN Arvinas
$33.26 /

-11.52 (-25.73%)

05/29/20 Roth Capital
Roth Capital recommends buying Arvinas on ASCO dip
05/29/20 Piper Sandler
Arvinas should be bought on weakness after ASCO update, says Piper Sandler
05/15/20 Roth Capital
Roth Capital maintains positive outlook on Arvinas after ASCO abstract review
05/13/20 Piper Sandler
Arvinas pullback represents a buying opportunity, says Piper Sandler
ARVN Arvinas
$33.26 /

-11.52 (-25.73%)

ARVN Arvinas
$33.26 /

-11.52 (-25.73%)

Hot Stocks
Gilead slips 2% after announcing results of trial in moderate COVID-19 patients » 08:53
06/01/20
06/01
08:53
06/01/20
08:53
GILD

Gilead

$77.80 /

+2.43 (+3.22%)

Gilead Sciences shares…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$77.80 /

+2.43 (+3.22%)

GILD Gilead
$77.80 /

+2.43 (+3.22%)

05/27/20 Raymond James
Raymond James keeps Market Perform on Gilead following Arcus partnership
05/27/20 Wedbush
Arcus Biosciences price target raised to $48 from $40 at Wedbush
05/27/20 Piper Sandler
Piper says partnership more favorable for Gilead than outright Arcus purchase
05/27/20 RBC Capital
Pullback in Gilead stock offers more attractive opportunity, says RBC Capital
GILD Gilead
$77.80 /

+2.43 (+3.22%)

GILD Gilead
$77.80 /

+2.43 (+3.22%)

GILD Gilead
$77.80 /

+2.43 (+3.22%)

GILD Gilead
$77.80 /

+2.43 (+3.22%)

Upgrade
JPMorgan upgrades Hess to Overweight on next upcycle positioning » 08:52
06/01/20
06/01
08:52
06/01/20
08:52
HES

Hess Corp.

$47.50 /

-0.99 (-2.04%)

JPMorgan analyst Arun…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HES Hess Corp.
$47.50 /

-0.99 (-2.04%)

HES Hess Corp.
$47.50 /

-0.99 (-2.04%)

05:10 Today JPMorgan
Hess Corp. upgraded to Overweight from Neutral at JPMorgan
05/08/20 Susquehanna
Hess Corp. price target raised to $54 from $45 at Susquehanna
03/20/20 Stephens
Stephens upgrades Hess, downgrades 11 others in E&P following oil's melt down
03/20/20 Stephens
Hess Corp. upgraded to Overweight from Equal Weight at Stephens
HES Hess Corp.
$47.50 /

-0.99 (-2.04%)

HES Hess Corp.
$47.50 /

-0.99 (-2.04%)

HES Hess Corp.
$47.50 /

-0.99 (-2.04%)

HES Hess Corp.
$47.50 /

-0.99 (-2.04%)

Initiation
Aspen Group assumed with a Buy at Craig-Hallum » 08:52
06/01/20
06/01
08:52
06/01/20
08:52
ASPU

Aspen Group

$8.38 /

+0.15 (+1.82%)

Craig-Hallum analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASPU Aspen Group
$8.38 /

+0.15 (+1.82%)

ASPU Aspen Group
$8.38 /

+0.15 (+1.82%)

03/11/20 Canaccord
Aspen Group top line growth remains robust, says Canaccord
01/06/20 Northland
Aspen Group named a Top Pick for 2020 at Northland
12/11/19 Lake Street
Aspen Group business model hitting its stride, says Lake Street
11/04/19 Northland
Aspen Group initiated with an Outperform at Northland
ASPU Aspen Group
$8.38 /

+0.15 (+1.82%)

Hot Stocks
Independence Realty Trust provides business update » 08:52
06/01/20
06/01
08:52
06/01/20
08:52
IRT

Independence Realty Trust

$9.92 /

-0.275 (-2.70%)

"IRT remains…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRT Independence Realty Trust
$9.92 /

-0.275 (-2.70%)

IRT Independence Realty Trust
$9.92 /

-0.275 (-2.70%)

03/10/20 Stifel
Independence Realty Trust upgraded to Buy from Hold at Stifel
10/31/19 Compass Point
Independence Realty Trust downgraded to Neutral from Buy at Compass Point
10/21/19 JMP Securities
Independence Realty Trust downgraded to Market Perform at JMP Securities
09/27/19 National Securities
Independence Realty Trust initiated with a Buy at National Securities
IRT Independence Realty Trust
$9.92 /

-0.275 (-2.70%)

Hot Stocks
SI-Bone announces $40M debt re-financing » 08:51
06/01/20
06/01
08:51
06/01/20
08:51
SIBN

SI-Bone

$17.61 /

+0.19 (+1.09%)

SI-BONE announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIBN SI-Bone
$17.61 /

+0.19 (+1.09%)

SIBN SI-Bone
$17.61 /

+0.19 (+1.09%)

03/10/20 Morgan Stanley
SI-Bone EPS estimates cut at Morgan Stanley
03/10/20 Canaccord
SI-Bone fundamentals remain intact despite macro weakness, says Canaccord
02/19/20 Needham
SI-Bone initiated with a Buy at Needham
01/10/20 Cantor Fitzgerald
Cantor still bullish on Medical Devices & Suppliers heading into 2020
SIBN SI-Bone
$17.61 /

+0.19 (+1.09%)

Recommendations
Essent Group price target lowered to $48 from $56 at Susquehanna » 08:51
06/01/20
06/01
08:51
06/01/20
08:51
ESNT

Essent Group

$32.88 /

-0.785 (-2.33%)

Susquehanna analyst Jack…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESNT Essent Group
$32.88 /

-0.785 (-2.33%)

ESNT Essent Group
$32.88 /

-0.785 (-2.33%)

08:15 Today B. Riley FBR
B. Riley FBR upgrades Radian on better forbearance data trends
05/12/20 Deutsche Bank
Essent Group price target lowered to $47 from $58 at Deutsche Bank
03/26/20 MKM Partners
MKM Partners sees Mortgage Insurers as attractively valued
03/26/20 RBC Capital
Essent Group price target lowered to $36 from $62 at RBC Capital
ESNT Essent Group
$32.88 /

-0.785 (-2.33%)

ESNT Essent Group
$32.88 /

-0.785 (-2.33%)

Hot Stocks
Lexagene Holdings provides update on commercializing pathogen detection system » 08:50
06/01/20
06/01
08:50
06/01/20
08:50
LXXGF

Lexagene Holdings

$0.00 /

+ (+0.00%)

LexaGene Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LXXGF Lexagene Holdings
$0.00 /

+ (+0.00%)

LXXGF Lexagene Holdings
$0.00 /

+ (+0.00%)

04/28/20 Industrial Alliance
Lexagene Holdings initiated with a Speculative Buy at Industrial Alliance
General news
Treasury Action: Treasuries are sinking slightly as even as equity futures fade » 08:50
06/01/20
06/01
08:50
06/01/20
08:50

Treasury Action:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.